Neutralization of IL-1β after experimental stroke significantly reduced MMP2/9 activity in CCA plaques 7 days after stroke and increased fibrous cap thickness compared with control (isotype IgG) treatment, indicating a causative role of IL-1β in mediating inflammatory plaque degradation (Fig. 4d,e). The gene discussed is IL1B; the disease is stroke disorder.